Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

P Soares‐da‐Silva, N Pires… - Pharmacology …, 2015 - Wiley Online Library
Eslicarbazepine acetate (ESL) is a once daily antiepileptic drug (AED) approved by the
European Medicines Agency (EMA), the Food and Drug Administration (FDA) and Health …

Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures

GM Keating - CNS drugs, 2014 - Springer
Abstract Eslicarbazepine acetate (Aptiom®, Zebinix®) is approved for the adjunctive
treatment of partial-onset seizures in adults aged≥ 18 years. Adjunctive therapy with oral …

[HTML][HTML] Adjunctive eslicarbazepine acetate: a pooled analysis of three phase III trials

V Biton, JB Rogin, G Krauss, B Abou-Khalil, JF Rocha… - Epilepsy & Behavior, 2017 - Elsevier
Objective To assess the safety and efficacy of once-daily (QD) adjunctive eslicarbazepine
acetate (ESL). Methods This post-hoc pooled analysis of three randomized, placebo …

Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine

L Pazdera, MR Sperling, JH Harvey, MC Sam… - …, 2018 - Wiley Online Library
Objective To evaluate the influence of prior use of carbamazepine (CBZ) and other
antiepileptic drugs (AED s) with a putatively similar mechanism of action (inhibition of …

[PDF][PDF] Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

LC Wright - 2015 - academia.edu
Eslicarbazepine acetate (ESL) is a once daily antiepileptic drug (AED) approved by the
European Medicines Agency (EMA), the Food and Drug Administration (FDA) and Health …

[引用][C] The New Antiepileptic Drugs: Where Do They Belong in Our Armamentarium?

M Jasti - NEUROLOGY, 2015